Small Animal Laser
The Cutting Edge Portable MLS Laser represents the most advanced Therapy laser on the market today. This laser is different from any other laser commercially available because of its dual emissions- Continuous and Pulsated. Continuous and pulsated emissions each have attributes that benefit the patient in different ways. Continuous emission stimulates an anti-inflammatory effect and edema re-absorption, but with secondary analgesic effects. Pulsated emission has a more intense analgesic action, but the effect on the inflammatory process is reduced. MLS therapy is the first laser to incorporate both, simultaneously. Rhythm, perfection of intervals and intensity, and maximum coordination are of the hallmarks and differentiating features of this laser system.
What are the most common indications for therapy?
The most common MLS Therapy indications are pain relief, intervertebral disc disease, post surgical pain relief, degenerative joint disease, wound healing, arthritic conditions, muscular/skeletal system trauma, and inflammatory conditions.
What wavelengths are used in the MLS therapy?
MLS therapy uses both the 808nm and 905nm wavelengths simultaneously. The 808nm wavelength is delivered using continuous emission while the 905nm wavelength is delivered using pulsed emission.
Why are two wavelengths used?
MLS Therapy uses two wavelengths to overcome the limits of traditional Laser Therapy. Traditional Laser therapy does not deliver both wave lengths in a reinforcing and synchronized fashion. Continuous laser emissions act fast on inflammation, stimulating blood and lymphatic circulation and inducing fast re-absorption of fluid build ups; however they only have a secondary effect on pain, which is diminished after reducing the inflammatory process. Pulsed laser emissions, on the other hand, have a practically immediate effect on pain, since they are able to induce analgesia, interfering with the very transmission of the pain impulse to the higher brain centers, but they are less effective at treating inflammation and edema.
Is MLS Therapy approved by the FDA?
Yes, the FDA has approved the use of MLS therapy and it is also patented via the US Patent Office.
What is the advantage of MLS therapy over traditional low level lasers? (LLLT)
MLS Therapy is able to induce strong anti-inflammatory, anti-edema, and analgesic effects simultaneously and within a short period of time. LLLT cannot achieve these results because of the limitations of using one or two wavelengths that are not synchronized. The patented control system that generates the MLS pulse synchronizes the emissions to achieve results previously unattainable. Thanks to this characteristic synchronization, the various therapeutic effects not only take place at the same time but reciprocally reinforce each other.
What is Harmony?
Harmony is the name of the laser used in the veterinary market that utilizes the patented MLS Therapy. The name was chosen because of the relationship of the 2 wavelengths and how they work together, much like a symphony, both bringing different characteristics to the table and complementing the benefits of the other.
Is Harmony a class IV laser?
Yes, Harmony is a class IV laser with a peak power of 25 watts.
What is the depth of penetration of the Harmony laser?
The depth of penetration will vary based on the animal but it is safe to assume that it will penetrate 4-5 cm on most animals.
How many treatments are usually needed to see results?
Results can often been seen after the first treatment. Most conditions have protocols that range from 6-10 treatments. The treatments are cumulative and are delivered 2-3 times per week for 2-3 weeks.
What is the cost of each treatment?
The treatments can range from $40 to $60 per treatment. The most common is a 6 treatment package sold for $260-$300.
How was MLS Therapy developed and tested?
MLS Therapy has been developed and tested following a strict course of biomedical and clinical research. The effectiveness of the combination of the emissions making up the MLS pulse was initially tested in vitro on cellular cultures, then in vivo on animals, and finally by means of controlled clinical trials run by major state-of-the-art health organizations for treating traumatic and degenerative painful diseases.